What Is Journavx?

Journavx (Suzetrigine) is a first-in-class non-opioid pain medication that works by selectively blocking NaV1.8 sodium channels in peripheral nerves to treat moderate to severe acute pain in adults.

If you've been prescribed Journavx — or you're researching it because you want to avoid opioids — this guide covers everything you need to know: what it is, how to take it, who shouldn't take it, how much it costs, and where to find it.

The Basics: Brand Name, Generic, and Manufacturer

• Brand name: Journavx
• Generic name: Suzetrigine (also known as VX-548 during clinical trials)
• Drug class: NaV1.8 sodium channel blocker; non-opioid analgesic
• Manufacturer: Vertex Pharmaceuticals
• FDA approval: January 2025
• Controlled substance: No — Journavx is not a controlled substance and has no DEA scheduling
• Available form: 50 mg oral tablets (blue, film-coated, oblong, debossed with "VX50")

Journavx is the first medication in its class to receive FDA approval. It represents a fundamentally new approach to pain management — one that doesn't involve opioids, NSAIDs, or acetaminophen.

What Is Journavx Used For?

Journavx is FDA-approved for moderate to severe acute pain in adults. This includes pain from:

• Surgery (orthopedic, abdominal, dental, and other procedures)
• Injuries and trauma
• Dental procedures and extractions
• Other short-term painful conditions

It is designed for short-term use — meaning you take it for the duration of acute pain, not indefinitely. Your doctor will prescribe it for the shortest effective duration.

Important: Journavx is not currently approved for chronic pain conditions. Clinical trials for diabetic peripheral neuropathy showed some promise, but this is not yet an FDA-approved use.

How Is Journavx Taken?

Here's how the dosing works:

• First dose: 100 mg (two 50 mg tablets) taken on an empty stomach — at least 1 hour before or 2 hours after eating. This ensures the medication is absorbed quickly.
• After that: 50 mg (one tablet) every 12 hours
• Maximum supply: 61 tablets per 30-day prescription

Important Dosing Notes

• Swallow tablets whole. Do not crush, break, or chew them.
• The first dose should be taken on an empty stomach for faster onset. Subsequent doses can be taken with or without food.
• If you have moderate liver impairment (Child-Pugh B), your doctor will adjust your dosing — after the fifth dose, you'll take 50 mg every 24 hours instead of every 12 hours.
• If you miss a dose, take it as soon as you remember unless it's close to your next dose. Don't double up.

For more on how the drug works in your body, see our article on how Journavx works.

Who Should Not Take Journavx?

Journavx is not appropriate for everyone. You should not take it if:

• You have severe liver impairment (Child-Pugh C) — Journavx is contraindicated in this population.
• You take strong CYP3A inhibitors — These medications are contraindicated with Journavx because they can dangerously increase Suzetrigine levels in your blood. Examples include:
  • Ketoconazole and Itraconazole (antifungals)
  • Clarithromycin (antibiotic)
  • Ritonavir, Cobicistat, Nelfinavir, Saquinavir (HIV medications)
  • Elvitegravir/Cobicistat/Emtricitabine/Tenofovir (HIV combination therapy)

Additionally, tell your doctor before starting Journavx if:

• You are pregnant, planning to become pregnant, or breastfeeding — safety has not been established.
• You use hormonal contraceptives — Journavx can reduce their effectiveness. You may need additional or alternative non-hormonal contraception during treatment and for 28 days after stopping.
• You take moderate CYP3A inhibitors like Erythromycin, Fluconazole, Diltiazem, or Verapamil — dose adjustments may be needed.

For a full list of drug interactions, read our guide on Journavx drug interactions.

How Much Does Journavx Cost?

Without insurance, Journavx costs between $477 and $657 for 30 tablets (50 mg each). There is currently no generic version available — the patent is not expected to expire until around 2040.

Insurance Coverage

Many insurance plans don't yet cover Journavx or require prior authorization. Common rejection codes include:

• Code 70 — Not covered
• Code 75 — Prior authorization required
• Code MR — Not on formulary

Congressional legislation is underway to improve Medicare coverage for non-opioid pain treatments, which may help in the near future.

Savings Programs

Vertex Pharmaceuticals offers the JOURNAVX+you Patient Savings Program:

• Commercially insured with coverage: Pay as little as $30 per fill (up to 61 tablets per 30-day supply, max benefit $1,000 per fill)
• Insured without coverage: The 2026 savings program covers up to 122 tablets (60-day supply) through June 30, 2026
• Patient Assistance Program: Eligible patients may receive Journavx at no charge through the Vertex Patient Assistance Program at journavx.com/support

For more ways to save, see our complete guide on how to save money on Journavx.

Where Can I Find Journavx?

Because Journavx is a newly launched medication, not every pharmacy stocks it yet. You can use Medfinder to check which pharmacies near you have Journavx in stock. For more detailed strategies, read our guide on how to find Journavx in stock near you.

Final Thoughts

Journavx is a genuinely new kind of pain medication. It's the first NaV1.8 blocker to reach the market, offering patients a non-addictive alternative to opioids for moderate to severe acute pain. While it comes with a high price tag and limited pharmacy availability in 2026, savings programs and expanding insurance coverage are making it more accessible.

If you think Journavx might be right for you, talk to your doctor — and read up on Journavx side effects and how to find a doctor who prescribes it to be prepared.